论文部分内容阅读
目的探讨依达拉奉用于急性脑梗死患者的疗效。方法将我院2009年1—6月收治的42例急性脑梗死患者随机分为治疗组和对照组各21例。二组均予常规治疗,治疗组在此基础上加用依达拉奉,观察二组的治疗效果。结果治疗组的基本痊愈率和进步率显著高于对照组,神经功能缺损评分低于对照组。结论依达拉奉可改善脑梗死所致神经功能缺损症状;加速受损神经功能恢复;降低伤残率,提高生存质量。
Objective To investigate the efficacy of edaravone in patients with acute cerebral infarction. Methods Forty-two patients with acute cerebral infarction admitted in our hospital from January to June in 2009 were randomly divided into treatment group (21 cases) and control group (21 cases). The two groups were given conventional treatment. The treatment group added edaravone on the basis of the above treatment to observe the treatment effect of the two groups. Results The basic cure rate and progress rate of the treatment group were significantly higher than those of the control group, and the score of neurological deficit was lower than that of the control group. Conclusion Edaravone can improve the symptoms of neurological deficits caused by cerebral infarction, accelerate the recovery of damaged nerve, reduce the disability and improve the quality of life.